TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Thern Medicine AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,797
|
1,215
|
243 |
Financial expenses |
33
|
22
|
0 |
Earnings before taxes |
138
|
199
|
-85 |
EBITDA |
105
|
231
|
-84 |
Total assets |
532
|
410
|
108 |
Current assets |
407
|
282
|
68 |
Current liabilities |
525
|
337
|
123 |
Equity capital |
7
|
73
|
-131 |
- share capital |
51
|
47
|
49 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
1.3%
|
17.8%
|
-121.3% |
Turnover per employee |
898
|
608
|
122 |
Profit as a percentage of turnover |
7.7%
|
16.4%
|
-35.0% |
Return on assets (ROA) |
32.1%
|
53.9%
|
-78.7% |
Current ratio |
77.5%
|
83.7%
|
55.3% |
Return on equity (ROE) |
1971.4%
|
272.6%
|
64.9% |
Change turnover |
495
|
980
|
-207 |
Change turnover % |
38%
|
416%
|
-46% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.